The Effectiveness of Convalescent Plasma for the Treatment of Novel Corona Virus Disease 2019: A Systematic Review and Meta-Analysis
Medicine
[키워드] 28-day mortality
95% CI
Analysis
antibody
CBM
CCP
CNKI
conducted
control group
convalescent plasma
Corona
Coronavirus disease 2019
COVID-19
criteria
Critical
critical COVID-19 patient
Efficacy and safety
enrolled
Evidence
group
hospital
Hospital stay
ICU
ICU admission
incidence
Infection
Inflammatory
Intervention
mechanical ventilation
Meta-analysis
Mortality
mortality rate
no significant difference
novel
Novel coronavirus
overall mortality
participant
Patient
patients with COVID-19
PICOS
Placebo
placebo group
plasma
Primary outcome
Randomized controlled trial
RCT
RCTs
reduce
reducing
review
safety and efficacy
searched
secondary outcome
Serious Adverse Events
significant difference
significantly
significantly shorter
SSRN
subgroup analysis
subject
therapy
Treatment
treatment group
treatments of COVID-19
VIP
viral loads
Web of Science
worldwide pandemic
[DOI] 10.3389/fmed.2021.641429 PMC 바로가기 [Article Type] Medicine
[DOI] 10.3389/fmed.2021.641429 PMC 바로가기 [Article Type] Medicine